» Articles » PMID: 39276053

[Protective Effect of Flos Extract Against Doxorubicin-induced Liver Injury in Mice]

Overview
Specialty General Medicine
Date 2024 Sep 14
PMID 39276053
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To explore the mechanism underlying the protective effect of flos (LJF) extract against doxorubicin (DOX) -induced liver injury in mice.

Methods: Network pharmacology methods were used to obtain the intersection genes between LJF targets and disease targets, based on which the protein-protein interaction (PPI) network was constructed using STRING database for screening the core targets using Cytoscape software. DAVID database was used for bioinformatics analysis, and the core components and core targets were verified using molecular docking study. In a mouse model of DOX-induced liver injury, the effect of LJF extract on liver pathologies, serum levels of ALT and AST, and hepatic expressions of HYP, ROS, TNF-α, IL-6, COL-Ⅳ and P53 proteins were evaluated using HE and Masson staining, ELISA, and Western blotting.

Results: We identified 12 core targets from 43 intersection genes involving cancer pathway, IL-17 signaling pathway, and TNF signaling pathways. Molecular docking study suggested that 10 core components of LJF could bind to different core targets. The mice with DOX-induced liver injury showed elevated serum AST and ALT levels with obvious liver injury and fibrosis, increased ROS content, and enhanced expressions of TNF-α, IL-6, HYP, COL-Ⅳ and P53 proteins in the liver tissue. All these changes in the mouse models were significantly alleviated by treatment with LJF extract, suggesting obviously lowered levels of oxidative stress, inflammation and fibrosis in the liver tissues.

Conclusion: LJF extract is capable of alleviating DOX-induced liver injury in mice by downregulating Trp53, TNF and IL-6 to reduce liver oxidative stress, inflammation and fibrosis.

References
1.
Alasmari A, Alharbi M, Alqahtani F, Alasmari F, Alswayyed M, Alzarea S . Diosmin Alleviates Doxorubicin-Induced Liver Injury via Modulation of Oxidative Stress-Mediated Hepatic Inflammation and Apoptosis via NfkB and MAPK Pathway: A Preclinical Study. Antioxidants (Basel). 2021; 10(12). PMC: 8698866. DOI: 10.3390/antiox10121998. View

2.
Wali A, Rashid S, Rashid S, Ansari M, Khan M, Haq N . Naringenin Regulates Doxorubicin-Induced Liver Dysfunction: Impact on Oxidative Stress and Inflammation. Plants (Basel). 2020; 9(4). PMC: 7238146. DOI: 10.3390/plants9040550. View

3.
Zhang Q, Zhang M, Liu Y, Lv F, Wang Y . [Exploring the therapeutic mechanism of decoction for perimenopausal insomnia based on network pharmacology and animal experiments]. Nan Fang Yi Ke Da Xue Xue Bao. 2023; 43(9):1536-1547. PMC: 10563099. DOI: 10.12122/j.issn.1673-4254.2023.09.11. View

4.
Chen M, Yi Y, Chen B, Zhang H, Dong M, Yuan L . Metformin inhibits OCTN1- and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice. Toxicology. 2024; 503:153757. DOI: 10.1016/j.tox.2024.153757. View

5.
Aon-Im P, Monthakantirat O, Daodee S, Chulikhit Y, Sriya N, Boonyarat C . Evaluation of the Impact of (Mart.) Griseb. Extract on Memory Impairment in D-Galactose-Induced Brain Aging in Mice through Its Effects on Antioxidant Enzymes, Neuroinflammation, and Telomere Shortening. Molecules. 2024; 29(2). PMC: 10818586. DOI: 10.3390/molecules29020503. View